Sniper-Traders

Jubilant Pharmova Ltd : Looking for buy

Long
NSE:JUBLPHARMA   JUBILANT PHARMOVA LTD
Expecting a potential upside of about 70%.

They supply products and services to customers in over 85 countries. They have four manufacturing facilities in North America and two in India, coupled with Research and Development centres in North America and India. Additionally, they have a distribution network of more than 45 radiopharmacy in the United States.

Leadership Positions
Radiopharmaceuticals
Third largest radiopharmaceutical manufacturer in the nuclear medicine industry in the United States based on revenue
Second largest centralized commercial radiopharmacy network in the United States with a national footprint of more than 45 radiopharmacies across 22 states
Allergy Therapy Products
One of the top three players with a market share of 25% in the allergenic extract market in the United States and are currently the sole producer and supplier of venom products for the treatment of allergies in the United States
APIs
Among the leading global suppliers for several Key APIs.
Solid Dosage Formulations
One of the market leaders in the United States, based on the market share of several key products.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.